CCM
LJPC

Cadence Capital Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Cadence Capital Management’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-12,060
Closed -$326K – 706
2015
Q4 		$326K Buy
+12,060
New +$329K 0.02% 537

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cadence Capital Management's LJPC Position: Q1 2016 in Review

Cadence Capital Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q1 2016, closing a stake of 12,060 shares — an estimated $326K sold.

Cadence Capital Management first reported a position in LJPC in Q4 2015 and held it in 1 quarter. The position peaked at $326K in Q4 2015. 70 funds tracked by Wall St. Rank hold LJPC as of Q1 2016.

  • Cadence Capital Management reported no remaining La Jolla Pharmaceutical Company position as of Q1 2016 after selling out during the quarter.
  • Cadence Capital Management sold 12,060 La Jolla Pharmaceutical Company shares in Q1 2016, an estimated $326K.
  • Cadence Capital Management first reported a position in La Jolla Pharmaceutical Company in Q4 2015 and held it in 1 quarter.
  • Cadence Capital Management's La Jolla Pharmaceutical Company position peaked at $326K in Q4 2015.
  • 70 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2016.

Based on Cadence Capital Management's 13F filing for Q1 2016, filed 2 May 2016.